Holly Springs, NC, Sep 22, 2026 — The Wake County Board of Commissioners voted 5-2 at its Monday meeting to approve amendments allowing Atrium Health to become the sole corporate member of WakeMed, clearing a major hurdle for the county’s public safety-net hospital system to join the Charlotte-based Advocate Health enterprise.
Two protections commissioners repeatedly cited in explaining their votes, however, aren’t included in the documents they approved: a guarantee that Atrium will provide the money for a $2 billion capital commitment and a limit on rate increases. Those provisions currently rest on a letter from Atrium and assurances from county attorneys. They are expected to be incorporated into a separate agreement between WakeMed and Atrium that will not be made public.
WakeMed operates three community hospitals, its main Raleigh campus, Cary Hospital and North Hospital, along with specialty rehabilitation and mental health hospitals. The system has a combined 973 licensed beds and nearly 12,900 employees. In its most recently reported fiscal year, WakeMed recorded more than 354,000 emergency visits and 71,000 patient discharges.
The vote followed hours of public comment, staff presentations, and commissioner debate. Roughly 50 residents, hospital employees, advocacy group representatives, and Atrium and WakeMed staff addressed the board, with most of those who spoke urging commissioners to reject the proposal or postpone a decision. Commissioners Waters and Adamson voted no. Chair Don Mial and Commissioners Jackson, Stallings, Evans and Thomas voted yes.
“With a broken heart, I vote no,” Adamson said before the roll call.
Atrium’s new role
The transaction doesn’t merge WakeMed into Atrium or transfer WakeMed’s assets. WakeMed remains a separate legal entity with its name, nonprofit status and existing 14-member board structure. The significant change is that Atrium becomes WakeMed’s sole corporate member, a role nonprofit corporations can use in place of shareholders under North Carolina law.
County attorneys described the change as “very drastic” compared with WakeMed’s current governance structure because it gives Atrium authority it doesn’t have today. They also distinguished the arrangement from a merger, in which one corporation would cease to exist, and from an asset transfer such as those involving Mission Hospital and New Hanover Regional Medical Center.
The agreements commissioners approved
Monday’s vote covered two documents: amended and restated Articles of Incorporation for WakeMed and a second amendment to the 1997 Transfer Agreement between Wake County and WakeMed. Approval doesn’t immediately complete the transaction. The combination remains subject to federal antitrust review under the Hart-Scott-Rodino Act, and county attorney Roger Askew told commissioners that if federal regulators reject it, the documents approved Monday become null and void.
The board also placed conditions on Chair Don Mial’s authority to sign the amended transfer agreement. Those conditions include a guarantee that Atrium’s promised $2 billion capital investment will be funded by Atrium rather than WakeMed and a five-year limit on rate increases of 1.5 times the annual Medicare reimbursement adjustment.
Neither provision appears in the Articles of Incorporation or amended transfer agreement.
The two commitments came from a Sept. 19th letter from Atrium’s CEO to Governor Josh Stein after the governor intervened publicly in the proposed transaction during the weekend before the vote. The terms are expected to become part of a separate Member Addition Agreement between Atrium and WakeMed. That agreement wasn’t before commissioners Monday and isn’t public. Askew said state law permits the hospitals to withhold it as competitive business information.
Askew told commissioners he will review the final language and won’t allow the chair to sign the transfer agreement if the Member Addition Agreement doesn’t reflect the commitments Atrium has made.
Governance changes
Wake County will continue to appoint eight of WakeMed’s 14 directors, with Atrium appointing the other six. County appointees will now be required to live in Wake County, a requirement that doesn’t apply to Atrium’s appointees.
Before closing, the county will seat its initial eight directors, five of whom must be current WakeMed board members. That requirement was added during negotiations in the final days before the vote. The final documents also restore WakeMed’s more specific standards for removing county-appointed directors for cause after an earlier version contained broader language that could have allowed removal for such reasons as failing to collaborate effectively with other board members.
Atrium also gains significant authority over WakeMed management. The WakeMed board keeps its existing power to fire the CEO, but Atrium will have the ability to terminate the CEO without action by the board.
Money, indigent care and debt collection
The amended transfer agreement increases WakeMed’s minimum indigent-care requirement from 4.8% to 8% of a defined measure of patient revenue, the first increase in that minimum since 2008. Atrium will also fund a new $150 million Wake County Whole Health Program through annual payments of $15 million for 10 years. The county will direct the money toward housing, homelessness, food security, and behavioral health programs.
The $2 billion capital commitment changed significantly during negotiations. An earlier proposal allowed the investment to include money generated by WakeMed through operating revenue and investment income and contemplated spending it over 10 to 13 years. Under Atrium’s latest commitment, the full $2 billion would come from Atrium over 15 years. That funding guarantee is contained in the correspondence with the governor rather than the agreements commissioners approved Monday.
During the presentation, Askew gave two figures for the amount of the $2 billion expected to go toward routine facility improvements, first citing approximately $400 million and later $460 million. The difference wasn’t resolved during the meeting and couldn’t be reconciled from the documents reviewed. Four projects were specifically identified: a Garner health campus, a Rolesville health facility, an expansion of WakeMed’s North Tower and expansion of its emergency department and trauma center.
The agreement also prohibits WakeMed from using a series of aggressive debt-collection practices. The hospital won’t be permitted to sell patient debt, report patients to credit bureaus, place liens, garnish wages, or pursue arrest over unpaid medical bills.
Askew said failure to fulfill the $2 billion capital commitment or comply with the debt-collection provisions would constitute a contractual issue to be pursued through WakeMed’s county-appointed board members. Neither would allow Wake County to reclaim hospital property.
The county’s property reversion rights apply if WakeMed stops operating as a nonprofit community hospital, engages in discrimination, or fails to meet the 8% indigent-care requirement. Even then, those rights don’t extend across the WakeMed system. They cover the main Raleigh campus and a portion of the Cary campus.
Objections to the process
For Waters and Adamson, the process leading to Monday’s vote was among the reasons for opposing the transaction. Both said important terms continued to change shortly before the meeting. The rate limit and guarantee surrounding the source of the $2 billion commitment arrived only days before commissioners voted, and some language wasn’t available when the meeting agenda was posted.
Waters also objected to holding the vote on Yom Kippur, saying the timing prevented some Jewish residents from participating. She argued that the compressed timeline made it harder for the public to have confidence that its questions and concerns had been fully considered.
Commissioners who supported the transaction also acknowledged shortcomings in the process. Evans and Thomas said the agreement had improved substantially from the proposal commissioners first reviewed in the spring, when the county would have had considerably less influence over WakeMed’s future.
Jackson, who made the motion for approval, pointed to protections commissioners had negotiated into the agreement while saying public scrutiny shouldn’t end with Monday’s vote. She called for continued attention to whether the commitments made during negotiations are fulfilled.
Opponents also raised concerns about what Atrium’s involvement could eventually mean for health-care prices. Two speakers cited an analysis they attributed to Brown University researchers, saying prices at Wake Forest Baptist Medical Center increased 28% from 2020 through 2024 following Atrium’s 2020 acquisition, compared with approximately 20% at other North Carolina hospitals.
The underlying research wasn’t independently verified for this report, so those figures remain claims made by speakers at the meeting rather than independently established findings.
“That is not a partnership. That is a change of ownership dressed up in governance language,” said Grant Welch, the Communications Workers of America’s North Carolina legislative political director, who spoke against the proposal.
Jackson placed the WakeMed transaction in a larger context, describing it as part of “a 15- to 20-year national and state consolidation trend” involving hospitals.
What happens now
Monday’s vote doesn’t close the transaction. Federal antitrust review must be completed first, and the final language governing the source of Atrium’s $2 billion investment and the five-year rate limit will be contained in the Member Addition Agreement between Atrium and WakeMed rather than the public agreements approved by commissioners.
Askew said he will share that language with commissioners before the transaction is signed but did not provide a timetable for when that will occur. The Member Addition Agreement itself will remain non-public.